These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3124432)

  • 1. Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
    Chomienne C; Najean Y; Degos L; Thomas G; Baumelou E; Calvo F; Casassus P; Ciccone F; Fenaux P; Gris JC
    Acta Haematol; 1987; 78 Suppl 1():109-15. PubMed ID: 3124432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

  • 3. Low dose Ara-C for patients with myelodysplastic syndromes.
    Powell BL; Capizzi RL; Jackson DV; Richards F; Muss HB; Lyerly ES; Rosenbaum DL; Connelly RA; Buss DH; Bearden JD
    Leukemia; 1988 Mar; 2(3):153-6. PubMed ID: 3347093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose cytosine arabinoside in myelodysplastic syndromes.
    Martiat P; Mineur P; Ferrant A; Michaux JL
    Acta Clin Belg; 1986; 41(2):83-8. PubMed ID: 3751444
    [No Abstract]   [Full Text] [Related]  

  • 5. Low dose cytosine arabinoside therapy in myelodysplastic syndrome and acute myeloid leukemia.
    Katayama N; Tanaka I; Minami N; Shirakawa S
    Jpn J Clin Oncol; 1987 Jun; 17(2):117-21. PubMed ID: 3475489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
    Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
    Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group.
    Gerhartz HH; Marcus R; Delmer A; Zwierzina H; Suciu S; Dardenne M; Solbu G; de Witte T; Jacobs A; Visani G
    Leukemia; 1994 Jan; 8(1):16-23. PubMed ID: 8289481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of small doses cytosine arabinoside (Ara-C) on leukemic cells in vitro and in vivo. Results in patients with leukemia and myelodysplastic syndrome.
    Kuliczkowski K; Kotlerek-Haus S; Frydecka I; Sedek K; Nowicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):738-48. PubMed ID: 2436986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes.
    Ho AD; Martin H; Knauf W; Reichardt P; Trümper L; Hunstein W
    Leuk Res; 1987; 11(11):1041-4. PubMed ID: 3320577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of myelodysplastic syndrome using continual subcutaneous infusion of low doses of cytosine arabinoside].
    Vozobulová V; Koza V; Cepelák V; Neuwirtová R; Masek Z
    Vnitr Lek; 1990 May; 36(5):483-8. PubMed ID: 2375080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose cytosine arabinoside in myelodysplastic syndromes.
    Mineur P; Martiat P; Ferrant A; Michaux JL
    Acta Clin Belg; 1989; 44(1):62-3. PubMed ID: 2763785
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome.
    Clark RE; Ismail SA; Jacobs A; Payne H; Smith SA
    Br J Haematol; 1987 May; 66(1):77-83. PubMed ID: 3297129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose cytosine arabinoside in the treatment of the primary myelodysplastic syndrome.
    Pluta A; Kowalewski J; Kurowska M; Spiewak H; Hus M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):787-91. PubMed ID: 1713883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose cytosine arabinoside in the treatment of myelodysplastic syndrome.
    Nair R; Saikia TK; Gopal R; Nair CN; Soman CS; Advani SH
    J Assoc Physicians India; 1996 Mar; 44(3):181-3. PubMed ID: 9251314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytosine arabinoside in low doses in the treatment of myelodysplastic syndrome. Czechoslovak MDS Cooperative Group].
    Neuwirtová R
    Vnitr Lek; 1992 Jan; 38(1):27-32. PubMed ID: 1561770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose cytosine arabinoside in patients with acute myeloblastic leukemia and myelodysplastic syndrome.
    Heyll A; Aul C; Heyll U; Schneider W
    Haematol Blood Transfus; 1987; 30():322-5. PubMed ID: 3476364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute myeloblastic leukemias and myelodysplasias: treatment with low doses of aracytine].
    Pignon B; Blaise AM; Boilletot A; Herbrecht R; Rozenbaum A; Flesch M; Audhuy B; Barats JC
    Nouv Rev Fr Hematol (1978); 1986; 28(6):345-8. PubMed ID: 3470706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
    Zwierzina H; Suciu S; Loeffler-Ragg J; Neuwirtova R; Fenaux P; Beksac M; Harousseau J; Nuessler V; Cermak J; Solbu G; Willemze R; de Witte T; Amadori S;
    Leukemia; 2005 Nov; 19(11):1929-33. PubMed ID: 16151466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia.
    Maiolo AT; Foa P; Cortellaro M; Lambertenghi-Deliliers G; Colantoni A; Cesana B; Castoldi GL; Cazzola M; Giordano M; Riccardi A
    Haematologica; 1987; 72(1):61-5. PubMed ID: 3108098
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.
    Murray M; Sarsfield P; Lawlor E; McCann SR
    Ir J Med Sci; 1988 Jul; 157(7):238-41. PubMed ID: 3170148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.